$STLT is heading the wrong way on typical low volume (due to the ultra low float) for tax loss selling season. An interesting indicator, as it has gaped up some, and is looking like it wants to run.

I still need to log onto their online site and order the rub on pain reliever they just started selling on line for $20, that they hope to take on the opioid crisis with. They already have sales as the last 10-Q they filled, shw they produced a 1/4 million dollar inventory of it this year, but the 1-2 weeks of sales in the 10-Q was only about $1000 so far, so the market is not really jumping on it yet.

But the rub on ointment is said to be great for arthritis pain, and I have RA pain bad at times. The ingredient is a derivative of cobra snake venom!!!

https://ir.spotlightinnovation.com/press-releases/detail/66

Derived from Cobra venom. They also have cancer drug trials underway based on the cobra venom derivatives.
Company latest product investor pdf:

https://content.equisolve.net/_b04594007f3c81...r+2017.pdf